Advertisement

Pediatric Cardiology

, Volume 34, Issue 1, pp 189–193 | Cite as

Successful Implantation of an Intracardiac Defibrillator in an Infant With Long QT Syndrome and Isolated Noncompaction of the Ventricular Myocardium

  • Ozge Surmeli Onay
  • Isil Yildirim
  • Burcin Beken
  • Sevcan Erdem
  • Tevfik Karagoz
  • Mustafa Yilmaz
  • Sule Yigit
Case Report

Abstract

Congenital long QT syndrome (LQTS) is an inherited disorder characterized by QT prolongation and polymorphic ventricular tachycardia known as torsade de pointes. The underlying cellular mechanism is prolonged ventricular repolarization caused by mutations in genes encoding cardiac ion channels or membrane adaptors. The disease can be diagnosed at any age and, very rarely, it can be diagnosed prenatally or in the neonatal period. Isolated noncompaction of the ventricular myocardium (INCVM) is defined as the presence of prominent ventricular trabeculations and deep intertrabecular recesses within the endomyocardium. This report describes a newborn baby presenting with polymorphic ventricular tachycardia whose diagnosis was LQTS and INCVM. Ventricular tachycardia did not respond to medical treatment, and a transient epicardial pacemaker was inserted surgically on his 30th day of life for atrioventricular block and bradycardia. The transient epicardial pacemaker was upgraded to an epicardial intracardiac defibrillator on his 40th day. The concomitant occurrence of INCVM, LQTS, and atrioventricular block needs to be evaluated further.

Keywords

Atrioventricular block ICD implantation Infant Isolated noncompaction of the ventricular myocardium Long QT syndrome 

References

  1. 1.
    Bauersfeld U, Tomaske M, Dodge-Khatami A, Rahn M, Kellenberger CJ, Prêtre R (2007) Initial experience with implantable cardioverter defibrillator systems using epicardial and pleural electrodes in pediatric patients. Ann Thorac Surg 84:303–305PubMedCrossRefGoogle Scholar
  2. 2.
    Berul CI, Triedman JK, Forbess J (2001) Minimally invasive cardioverter defibrillator implantation for children: an animal model and pediatric case report. Pacing Clin Electrophysiol 24:1789–1794PubMedCrossRefGoogle Scholar
  3. 3.
    Celiker A, Ozkutlu S, Dilber E, Karagöz T (2005) Rhythm abnormalities in children with isolated ventricular noncompaction. Pacing Clin Electrophysiol 28:1198–1202PubMedCrossRefGoogle Scholar
  4. 4.
    Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R (1990) Isolated noncompaction of left ventricular myocardium: a study of eight cases. Circulation 82:507–513PubMedCrossRefGoogle Scholar
  5. 5.
    Dorostkar PC, Eldar M, Belhassen B, Scheinman MM (1999) Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing. Circulation 100:2431–2436PubMedCrossRefGoogle Scholar
  6. 6.
    Drago F, Stefano Silvetti M, Annichiarico M et al (2010) Biventricular pacing in an infant with noncompaction of the ventricular myocardium, congenital AV block, and prolonged QT interval. J Interv Card Electrophysiol 28:67–70PubMedCrossRefGoogle Scholar
  7. 7.
    Elshershari H, Okutan V, Celiker A (2001) Isolated noncompaction of ventricular myocardium. Cardiol Young 11:472–475PubMedCrossRefGoogle Scholar
  8. 8.
    Garson A Jr, Dick M, Fournier A et al (1993) The long QT syndrome in children: an international study of 287 patients. Circulation 87:1866–1872PubMedCrossRefGoogle Scholar
  9. 9.
    Hoshino K, Ogawa K, Hishitani T, Isobe T, Etoh Y (2006) Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome. Pediatr Int 48:112–117PubMedCrossRefGoogle Scholar
  10. 10.
    Hoshino K, Ogawa K, Hishitani T, Isobe T, Eto Y (2004) Optimal administration dosage of magnesium sulfate for torsades de pointes in children with long QT syndrome. J Am Coll Nutr 23:497–500Google Scholar
  11. 11.
    Maron BJ, Towbin JA, Thiene G et al (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807–1816PubMedCrossRefGoogle Scholar
  12. 12.
    McNair WP, Ku L, Taylor MR et al (2004) SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Familial Cardiomyopathy Registry Research Group. Circulation 110:2163–2167PubMedCrossRefGoogle Scholar
  13. 13.
    Mendoza A, Belda S, Salguero R, Granados MA (2010) Congenital complete atrioventricular block associated with QT prolongation: description of a patient with an unusual outcome. Pediatr Cardiol 31:887–890PubMedCrossRefGoogle Scholar
  14. 14.
    Ogawa K, Nakamura Y, Terano K, Ando T, Hishitani T, Hoshino K (2009) Isolated noncompaction of the ventricular myocardium associated with long QT syndrome: a report of 2 cases. Circ J 73:2169–2172PubMedCrossRefGoogle Scholar
  15. 15.
    Pignatelli RH, McMahon CJ, Dreyer WJ et al (2003) Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation 108:2672–2678PubMedCrossRefGoogle Scholar
  16. 16.
    Ritter M, Oechslin E, Sütsch G, Attenhofer C, Schneider J, Jenni R (1997) Isolated noncompaction of the myocardium in adults. Mayo Clin Proc 72:26–31PubMedCrossRefGoogle Scholar
  17. 17.
    Salerno JC, Chun TU, Rutledge JC (2008) Sinus bradycardia, Wolff–Parkinson–White, and left ventricular noncompaction: an embryologic connection? Pediatr Cardiol 29:679–682PubMedCrossRefGoogle Scholar
  18. 18.
    Silver ES, Liberman L, Chung WK (2009) Long QT syndrome due to a novel mutation in SCN5A: treatment with ICD placement at 1 month and left cardiac sympathetic denervation at 3 months of age. J Interv Card Electropysiol 26:41–45CrossRefGoogle Scholar
  19. 19.
    Stephenson EA, Batra AS, Knilans TK (2006) A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol 17:41–46PubMedCrossRefGoogle Scholar
  20. 20.
    Tester DJ, Ackerman MJ (2011) Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice. Circulation 123:1021–1037PubMedCrossRefGoogle Scholar
  21. 21.
    Thøgersen AM, Helvind M, Jensen T, Andersen JH, Jacobsen JR, Chen X (2001) Implantable cardioverter defibrillator in a 4 month-old infant with cardiac arrest associated with a vascular heart tumor. Pacing Clin Electrophysiol 24:1699–1700PubMedCrossRefGoogle Scholar
  22. 22.
    Wang DW, Viswanathan PC, Balser JR, George AL Jr, Benson DW (2002) Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation 105:341–346PubMedCrossRefGoogle Scholar
  23. 23.
    Weiford BC, Subbarao VD, Mulhern KM (2004) Noncompaction of the ventricular myocardium. Circulation 109:2965–2971PubMedCrossRefGoogle Scholar
  24. 24.
    Zaragoza MV, Arbustini E, Narula J (2007) Noncompaction of the left ventricle: primary cardiomyopathy with an elusive genetic etiology. Curr Opin Pediatr 19:619–627PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Ozge Surmeli Onay
    • 1
  • Isil Yildirim
    • 2
  • Burcin Beken
    • 3
  • Sevcan Erdem
    • 4
  • Tevfik Karagoz
    • 2
  • Mustafa Yilmaz
    • 5
  • Sule Yigit
    • 1
  1. 1.Division of Neonatology, Department of PediatricsHacettepe University, Faculty of MedicineAnkaraTurkey
  2. 2.Division of Pediatric Cardiology, Department of PediatricsHacettepe University, Faculty of MedicineAnkaraTurkey
  3. 3.Department of PediatricsHacettepe University, Faculty of MedicineAnkaraTurkey
  4. 4.Pediatric Cardiology UnitCukurova University, Faculty of MedicineAdanaTurkey
  5. 5.Department of Cardiovascular SurgeryHacettepe University, Faculty of MedicineAnkaraTurkey

Personalised recommendations